You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brain Nicotinamide Adenine Dinucleotide (NAD )

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mild Cognitive Impairment, NAD Trial in San Antonio (Nicotinamide riboside, Sugar Pill)

Completed
  • Mild Cognitive Impairment
  • NAD
  • Nicotinamide riboside
  • Sugar Pill
  • San Antonio, Texas
  • +1 more
Aug 31, 2021

NAD Trial in Berlin (Niagen, Placebo)

Not yet recruiting
  • NAD
  • Niagen
  • Placebo
  • Berlin, Germany
    Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Aug 22, 2023

Genetic Variants in Nicotinamide Adenine Dinucleotide Synthesis

Active, not recruiting
  • Vacterl Association
  • Congenital Malformation
    • Rochester, Minnesota
      Mayo Clinic
    Jan 10, 2023

    Covid19, Long COVID-19, Post-COVID-19 Syndrome Trial in Ann Arbor (Naltrexone, NAD+)

    Completed
    • Covid19
    • +2 more
    • Ann Arbor, Michigan
      AgelessRx
    Jan 23, 2023

    Healthy Trial in Bergen (nicotinamide riboside, nicotinamide mononucleotide)

    Recruiting
    • Healthy
    • nicotinamide riboside
    • nicotinamide mononucleotide
    • Bergen, Vestland, Norway
      Haukeland University Hospital
    Jan 25, 2023

    Method Optimization for the Quantification of the NAD

    Completed
    • NAD
    • Laboratory method validation
    • Lausanne, Switzerland
      Clinical Innovation Lab.
    Sep 27, 2022

    Sarcopenia, Nicotinamide Adenine Dinucleotide Concentration, Muscle Quality and NAD+ Content Trial in Buffalo (Nicotinamide

    Recruiting
    • Sarcopenia
    • +2 more
    • Nicotinamide Riboside
    • Placebo
    • Buffalo, New York
      VA Western New York Healthcare System, Buffalo, NY
    Oct 19, 2021

    Aging Trial in Oklahoma City (Nicotinamide riboside, Placebo)

    Not yet recruiting
    • Aging
    • Nicotinamide riboside
    • Placebo
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    Aug 2, 2022

    Ketoses, Metabolic, Ketogenic Dieting, Alcohol Intoxication Trial in Philadelphia (dietary supplement, other, drug)

    Not yet recruiting
    • Ketoses, Metabolic
    • +4 more
    • Ketone Supplement
    • +3 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania Center for Studies of Addiction
    Sep 29, 2023

    Cognitive Impairment, Sleep Quality Trial in Buffalo (Nicotinamide riboside, Placebo)

    Not yet recruiting
    • Cognitive Impairment
    • Sleep Quality
    • Nicotinamide riboside
    • Placebo
    • Buffalo, New York
    • +1 more
    Aug 10, 2022

    Friedreich Ataxia Trial in Philadelphia (MIB-626)

    Active, not recruiting
    • Friedreich Ataxia
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Oct 26, 2022

    Mitochondrial Myopathies Trial in Helsinki (Niacin)

    Completed
    • Mitochondrial Myopathies
    • Niacin
    • Helsinki, Finland
      University of Helsinki
    Jan 21, 2021

    Alzheimer's Disease (Incl Subtypes), Dementia Trial in Boston (MIB-626, Placebo)

    Recruiting
    • Alzheimer's Disease (Incl Subtypes)
    • Dementia
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 11, 2022

    Gulf War Illness Trial in Fort Lauderdale, Sarasota (Nicotinamide Riboside, Placebo)

    Recruiting
    • Gulf War Illness
    • Nicotinamide Riboside
    • Placebo
    • Fort Lauderdale, Florida
    • +1 more
    Apr 25, 2022

    Enhance Immune Function Trial (NMN)

    Not yet recruiting
    • Enhance Immune Function
    • (no location specified)
    Aug 2, 2023

    Systemic Lupus Erythematosus (Sle) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Nicotinamide Riboside)

    Not yet recruiting
    • Systemic Lupus Erythematosus (Sle)
    • Nicotinamide Riboside
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Sep 15, 2023

    Alzheimer, Dementia Trial in Bergen (Placebo, Nicotinamide Riboside supplementation 1000mg daily in total, Nicotinamide Riboside

    Recruiting
    • Alzheimer Disease
    • Dementia
    • Placebo
    • +2 more
    • Bergen, Vestland, Norway
    • +1 more
    Nov 25, 2022

    Mild Cognitive Impairment, Mild Alzheimer Trial in Belmont (Nicotinamide riboside)

    Recruiting
    • Mild Cognitive Impairment
    • Mild Alzheimer Disease
    • Nicotinamide riboside
    • Belmont, Massachusetts
      McLean Hospital
    Mar 8, 2022

    Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release

    Recruiting
    • Migraine Prophylaxis
    • Nicotinic Acid 500 MG Extended Release Oral Tablet
    • +2 more
    • Dhaka, Bangladesh
      BSMMU
    May 5, 2023

    SARS-CoV-2 Infection, Acute Kidney Injury Trial in New York, San Antonio, Seattle (Placebo, Nicotinamide riboside)

    Active, not recruiting
    • SARS-CoV-2 Infection
    • Acute Kidney Injury
    • Placebo
    • Nicotinamide riboside
    • New York, New York
    • +3 more
    Oct 25, 2022

    Heart Failure, Systolic Trial in Seattle (nicotinamide riboside, Placebo)

    Completed
    • Heart Failure, Systolic
    • nicotinamide riboside
    • Placebo
    • Seattle, Washington
      University of Washington
    Jun 9, 2021

    Skeletal Muscle Trial in Orlando (Deuterated nicotinamide (D4-NAM) IV infusion, Skeletal muscle biopsy, Skin tissue biopsy)

    Recruiting
    • Skeletal Muscle
    • Deuterated nicotinamide (D4-NAM) IV infusion
    • +2 more
    • Orlando, Florida
      AdventHealth Translational Research Institute
    Aug 2, 2022

    COPD Trial in Copenhagen (Nicotinamide Riboside, Placebo)

    Recruiting
    • COPD
    • Nicotinamide Riboside
    • Placebo
    • Copenhagen, Denmark
      Respiratory Research Unit, Bispebjerg Hospital
    Jul 26, 2021

    AKI Trial in Rochester (Nicotinamide Riboside + Pterostilbene, Placebo)

    Recruiting
    • AKI
    • Nicotinamide Riboside + Pterostilbene
    • Placebo
    • Rochester, Minnesota
      Mayo Clinic
    Feb 9, 2022

    Sudden Sensorineural Hearing Loss Trial in Guangzhou (Coenzyme I for Injection + conventional treatment, Conventional treatment)

    Recruiting
    • Sudden Sensorineural Hearing Loss
    • Coenzyme I for Injection + conventional treatment
    • Conventional treatment
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    May 8, 2023